Cargando…
Mass spectrometry in clinical glycomics: The path from biomarker identification to clinical implementation
Over the past decades, the genome and proteome have been widely explored for biomarker discovery and personalized medicine. However, there is still a large need for improved diagnostics and stratification strategies for a wide range of diseases. Post-translational modification of proteins by glycosy...
Autores principales: | de Haan, N., Wuhrer, M., Ruhaak, L.R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600986/ https://www.ncbi.nlm.nih.gov/pubmed/34820521 http://dx.doi.org/10.1016/j.clinms.2020.08.001 |
Ejemplares similares
-
Glycomics using mass spectrometry
por: Wuhrer, Manfred
Publicado: (2012) -
Clinical Glycomics Employing Graphitized Carbon Liquid Chromatography–Mass Spectrometry
por: Stavenhagen, Kathrin, et al.
Publicado: (2014) -
Comparative Glycomics of Immunoglobulin A and G From Saliva and Plasma Reveals Biomarker Potential
por: Plomp, Rosina, et al.
Publicado: (2018) -
Mass Spectrometry Imaging for Glycome in the Brain
por: Hasan, Md. Mahmudul, et al.
Publicado: (2021) -
Mass Spectrometry-Based N-Glycomics of Colorectal Cancer
por: Sethi, Manveen K., et al.
Publicado: (2015)